MissionIR Articles
-
MissionIRNewsBreaks – 180 Life Sciences Corp. Announces New Board Appointments
KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC) that previously entered a definitive agreement to acquire 180 Life Sciences, a…
-
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Partnership with Imaging Specialists IAG Gives Tech Boost to Upcoming Brain Cancer Drug Trials
Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of…
-
Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy
Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Appoints Digital Media Exec as BIGtoken CEO
SRAX (NASDAQ: SRAX), a financial technology solutions provider, today announced that one of its board members, Malcolm CasSelle, will be appointed chief executive officer of BIGtoken, a wholly owned subsidiary of SRAX. In addition to…
-
MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Issues Update on Non-Compliance with Nasdaq Listing Requirements
Youngevity International (NASDAQ: YGYI), a leading multichannel lifestyle company operating in three distinct business segments, on Friday announced its receipt of a September 29, 2020, Staff Determination Letter (the “September Notification”) from the Listing Qualifications…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) CEO Discusses Strategic Business Models, Nascent Stage of B2C Platform
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which…
-
MissionIRNewsBreaks – Cybin Corp. CEO Eyes Opportunity in Psychedelics Space, Organic IP Expansion
Cybin Corp., a Canada-based, life-science company developing mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products, recently announced the appointment of Doug Drysdale as the company’s chief executive officer. Well recognized in the pharmaceutical space, Drysdale brings…
-
MissionIRNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics CIO Discusses Convergence of AI, Data and Biology on DojoLIVE!
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, was featured in a recent article discussing the appearance of one of its executives, Helomics CIO…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. Setting the Stage for Success in Bringing Novel Products to Market
180 Life Sciences, a clinical-stage biotechnology company, is focused on research to solve one of the world’s most significant drivers of disease – inflammation. The company currently has three programs for the development of novel…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Applauds President Trump’s Bold Action to Address Threat of Foreign Reliance on Critical Minerals
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium and vanadium in the United States, on Thursday announced that President Trump issued an Executive Order on Addressing the Threat to the Domestic…
-
VistaGen Therapeutics Inc. (NASDAQ: VTGN) is “One to Watch”
VistaGen’s product portfolio consists of three novel drug candidates that, together, target multiple anxiety disorders, depression disorders and neurological disorders Two of the company’s drug candidates have received an FDA fast track designation, including for…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Pricing of $19.2M Public Offering, Nasdaq Uplisting
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, today announced the pricing of an underwritten…
-
Trxade Group, Inc. (NASDAQ: MEDS) Ending Q3 Strong with Increased Investor Exposure
The company’s current independent pharmacy member base represents over 50% of the United States pharmaceutical market within that vertical Actively used in all 50 states with over 11,700 pharmacies in its network, serving around 15…
-
MissionIRNewsBreaks – Mullen Technologies Opens Pre-Sales for MX-05 Pure Electric SUV
Mullen Technologies Inc., an emerging electric vehicle (“EV”) manufacturer, which previously announced a definitive agreement to merge with Net Element (NASDAQ: NETE) in a stock-for-stock reverse merger, today announced that it is accepting preorders for its…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc.’s (CSE: WTER) (NASDAQ: WTER) A88 Infused(TM) to be Featured by DOT Foods as All-Natural Flavored Product
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its A88 Infused(TM) flavors will be a featured product offered by…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces BIGtoken to Become Separate Public Company
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, will be moving its BIGtoken platform to a separate, publicly traded company. BIGtoken empowers consumers to earn money and…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Achieves Critical Milestone for Production of Lead Drug Candidate
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its GMP manufacturer partner NCK A/S,…
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) CEO Discusses ‘Sea of Change’ to Future of Anxiety Treatment
VistaGen Therapeutics’ (NASDAQ: VTGN) CEO Shawn Singh authored a recent article for Life Science Leader titled, “The Future of Anxiety Treatment Will Be Drastically Different.” In the piece, Singh, an experienced professional who has dedicated…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters Updated LOI to Acquire 51% of Mobile Game Developer Csfctech
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its entry into an updated letter of…
-
MissionIRNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Appoints New COO to Lead Growth Strategy, Manage Partnership Initiatives
Creatd (NASDAQ: CRTD, CRTDW), the parent company and creator of the Vocal platform, today announced the appointment of Laurie Weisberg as its new chief operating officer. Weisberg currently sits on Creatd’s board of directors and…
Search Articles
Latest Articles
- Nutriband Inc. (NASDAQ: NTRB) CEO Showcases AVERSA(TM) Abuse Deterrent Transdermal Technology at Emerging Growth Conference
- D-Wave Quantum Inc. (NYSE: QBTS) Releases New Tools to Advance Quantum AI Innovation and Exploration
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical
- MissionIRNewsBreaks – GlobalTech Corp. (OTC: GLTK) Closes $1.4 Million Convertible Note Private Placement
- Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Seizes Opportunities amid Rising Global Platinum Jewelry Demand